Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

STimulation to Activate RespIration

Multi-center, randomized, controlled, open-label Phase 2 feasibility trial. Subjects on mechanical ventilation (MV) for acute hypoxemic respiratory failure (AHRF) with lung injury (including subjects who meet criteria for acute respiratory distress syndrome (ARDS)) will be randomized 2:1 to diaphragm neurostimulation-assisted ventilation (DNAV) using the AeroNova System plus lung-protective ventilation (Treatment) vs. lung-protective ventilation alone (Control).

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Lungpacer Medical Inc.Updated: Jul 1, 2026Locations: 7
Eligibility criteria

Male or female, 18 years or older, and [+8]

Hypoxemia is primarily attributable to acute exacerbation of chronic obstructive... [+12]

Status: Not yet recruiting

A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System

A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Lungpacer Medical Inc.Updated: Mar 17, 2026
Eligibility criteria

Are 18 years or older, and, [+3]

Invasive mechanical ventilation >90 days. [+17]